Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16742 | 574 | 38.9 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
869 | 10864 | LIPODYSTROPHY//HIV ASSOCIATED NEPHROPATHY//LIPOATROPHY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HIV MOL GRP | Address | 4 | 38% | 2% | 9 |
2 | MED INT MED INFECT DIS | Address | 3 | 60% | 1% | 3 |
3 | BODY COMPOSIT ANAL | Address | 2 | 67% | 0% | 2 |
4 | CATHERINE MACAULEY | Address | 2 | 67% | 0% | 2 |
5 | DRUG THERAPY VIROLOGY | Author keyword | 1 | 100% | 0% | 2 |
6 | EQUIPE HOMEOSTASIE PHOSPHATE | Address | 1 | 100% | 0% | 2 |
7 | INFECT DIS ALLERGY 1 | Address | 1 | 50% | 0% | 2 |
8 | HAEMATOL ONCOL SCI | Address | 1 | 23% | 1% | 5 |
9 | BONETWORK | Address | 1 | 27% | 1% | 4 |
10 | MINNC T PROGRAM | Address | 1 | 30% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABACAVIR LAMIVUDINE | 30 | 50% | 8% | 44 |
2 | OSTEOPENIA OSTEOPOROSIS | 24 | 91% | 2% | 10 |
3 | B LIGAND RANKL | 6 | 29% | 3% | 16 |
4 | US GENERAL POPULATION | 4 | 27% | 2% | 13 |
5 | TOTAL BODY COMPOSITION | 1 | 100% | 0% | 2 |
6 | ANTIRETROVIRAL THERAPY INITIATION | 1 | 30% | 1% | 3 |
7 | OPTIMIZED BACKGROUND REGIMEN | 1 | 11% | 1% | 7 |
8 | NRAMP1 GENE EXPRESSION | 1 | 50% | 0% | 1 |
9 | OSTEOSONOGRAPHY | 1 | 50% | 0% | 1 |
10 | ENDOTHELIAL ACTIVATION MARKERS | 1 | 19% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review | 2006 | 299 | 36 | 69% |
Skeletal health in adults with HIV infection | 2015 | 1 | 103 | 69% |
Aging with HIV: osteoporosis and fractures | 2014 | 4 | 30 | 87% |
Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS | 2015 | 3 | 42 | 21% |
Incident fractures in HIV-infected individuals: a systematic review and meta-analysis | 2013 | 11 | 28 | 82% |
Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients | 2012 | 24 | 63 | 79% |
Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers | 2010 | 98 | 99 | 54% |
The effects of untreated and treated HIV infection on bone disease | 2014 | 3 | 59 | 71% |
Low body weight mediates the relationship between HIV infection and low bone mineral density: A meta-analysis | 2007 | 62 | 46 | 52% |
Bone Health and Human Immunodeficiency Virus Infection | 2013 | 6 | 73 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIV MOL GRP | 4 | 38% | 1.6% | 9 |
2 | MED INT MED INFECT DIS | 3 | 60% | 0.5% | 3 |
3 | BODY COMPOSIT ANAL | 2 | 67% | 0.3% | 2 |
4 | CATHERINE MACAULEY | 2 | 67% | 0.3% | 2 |
5 | EQUIPE HOMEOSTASIE PHOSPHATE | 1 | 100% | 0.3% | 2 |
6 | INFECT DIS ALLERGY 1 | 1 | 50% | 0.3% | 2 |
7 | HAEMATOL ONCOL SCI | 1 | 23% | 0.9% | 5 |
8 | BONETWORK | 1 | 27% | 0.7% | 4 |
9 | MINNC T PROGRAM | 1 | 30% | 0.5% | 3 |
10 | CORNELL CLIN TRIALS UNIT | 1 | 27% | 0.5% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000137569 | LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB |
2 | 0.0000104387 | METROPOLITAN VASC SERV//RHEUMATIC MANIFESTATIONS//HIV ARTHRITIS |
3 | 0.0000093651 | HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN |
4 | 0.0000091261 | 1200 N STATE ST//ADRENAL RESERVE//ADRENOCORTICAL DYSFUNCTION |
5 | 0.0000086941 | HEPATIC OSTEODYSTROPHY//LIMB REGENERAT//UNITE INSERM U658 |
6 | 0.0000064201 | FOKI POLYMORPHISM//EXPT MED ENDOCRINOL LEGENDO//LEGENDO |
7 | 0.0000059493 | HIV WASTING//HIV WASTING SYNDROME//WASTING |
8 | 0.0000052516 | OSTEONECROSIS//CORE DECOMPRESSION//TRANSIENT OSTEOPOROSIS |
9 | 0.0000052420 | AIDS CHOLANGIOPATHY//ANAL DISEASES//ANAL ULCER |
10 | 0.0000049943 | VITAMIN D//25 HYDROXYVITAMIN D//VITAMIN D DEFICIENCY |